- Home
- SILO vs ACXP Comparison
SILO vs ACXP Comparison
Compare SILO & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- ACXP
- Stock Information
- Founded
- SILO 2010
- ACXP 2017
- Country
- SILO United States
- ACXP United States
- Employees
- SILO N/A
- ACXP N/A
- Industry
- SILO Apparel
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- SILO Consumer Discretionary
- ACXP Health Care
- Exchange
- SILO Nasdaq
- ACXP Nasdaq
- Market Cap
- SILO 5.9M
- ACXP 6.8M
- IPO Year
- SILO N/A
- ACXP 2021
- Fundamental
- Price
- SILO $0.70
- ACXP $4.34
- Analyst Decision
- SILO
- ACXP Strong Buy
- Analyst Count
- SILO 0
- ACXP 3
- Target Price
- SILO N/A
- ACXP $143.67
- AVG Volume (30 Days)
- SILO 948.9K
- ACXP 69.2K
- Earning Date
- SILO 11-11-2025
- ACXP 11-12-2025
- Dividend Yield
- SILO N/A
- ACXP N/A
- EPS Growth
- SILO N/A
- ACXP N/A
- EPS
- SILO N/A
- ACXP N/A
- Revenue
- SILO $72,102.00
- ACXP N/A
- Revenue This Year
- SILO $1.86
- ACXP N/A
- Revenue Next Year
- SILO N/A
- ACXP N/A
- P/E Ratio
- SILO N/A
- ACXP N/A
- Revenue Growth
- SILO N/A
- ACXP N/A
- 52 Week Low
- SILO $0.41
- ACXP $3.80
- 52 Week High
- SILO $3.37
- ACXP $44.00
- Technical
- Relative Strength Index (RSI)
- SILO 53.25
- ACXP 41.81
- Support Level
- SILO $0.58
- ACXP $4.09
- Resistance Level
- SILO $0.83
- ACXP $4.34
- Average True Range (ATR)
- SILO 0.05
- ACXP 0.36
- MACD
- SILO 0.01
- ACXP 0.11
- Stochastic Oscillator
- SILO 45.56
- ACXP 33.55
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.